Associations of ESR1 and ESR2 gene polymorphisms with metabolic syndrome and its components in postmenopausal women
Metabolic syndrome (MS) is a constellation of risk factors, which, when not treated, leads to the development of type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD). It is a prevalent condition, which is associated with the growing epidemic of sedentary lifestyle[1]. MS is diagnosed when at least three out of five following risk factors are present: central obesity, elevated serum triglycerides, low HDL cholesterol concentrations, impaired fasting glucose and elevated systolic (SBP) or/and diastolic blood pressure (DBP)[2].
Source: Maturitas - Category: Primary Care Authors: Karolina Ku źbicka, Dominik Rachoń, Anna Woziwodzka, Magda Rybicka, Krzysztof Piotr Bielawski Source Type: research
More News: Cardiology | Cholesterol | Coronary Heart Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Epidemics | Epidemiology | Genetics | Heart | Heart Disease | Metabolic Syndrome | Obesity | Primary Care | Women